Skip to main content
Erschienen in: Reactions Weekly 1/2021

01.04.2021 | Case report

Denosumab/ibandronic acid/tetracycline

Deterioration of bone marrow oedema, reduced bone mineral density and allergic symptoms: 3 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Schmidt T, et al. Outcome of Teriparatide Treatment on Fracture Healing Complications and Symptomatic Bone Marrow Edema in Four Adult Patients With Hypophosphatasia. JBMR Plus 3: No. 8, Aug 2019. Available from: URL: http://doi.org/10.1002/jbm4.10215 Schmidt T, et al. Outcome of Teriparatide Treatment on Fracture Healing Complications and Symptomatic Bone Marrow Edema in Four Adult Patients With Hypophosphatasia. JBMR Plus 3: No. 8, Aug 2019. Available from: URL: http://​doi.​org/​10.​1002/​jbm4.​10215
Metadaten
Titel
Denosumab/ibandronic acid/tetracycline
Deterioration of bone marrow oedema, reduced bone mineral density and allergic symptoms: 3 case reports
Publikationsdatum
01.04.2021
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2021
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-94222-7

Weitere Artikel der Ausgabe 1/2021

Reactions Weekly 1/2021 Zur Ausgabe

Case report

Antibacterials

Case report

Multiple drugs

Case report

Lipid-emulsion

Case report

Cemiplimab